Don haka, yanzu da aka tabbatar cewa babban mai cin riba a cikin Covid-19 "alurar rigakafin" gwal na gwal na shekaru biyu da suka gabata ba Pfizer ba ne, amma har yanzu abin ban mamaki wanda ba a san shi ba kuma a baya ƙaramin kamfanin na Jamus BioNTech, zai bayyana cewa wani abu yana buƙatar faɗi game da wane ne ya mallaki BioNTech.
Kamar yadda aka nuna a labarina na farko nan, don 2021 da 2022 a hade, BioNTech ya sami sama da dala biliyan 31 a cikin ribar "alurar rigakafi" na Covid-19 akan wani ribar da ta kai kashi 77 cikin dari idan aka kwatanta da Pfizer na kusan dala biliyan 20 akan kimanin kashi 27.5 na ribar.
Wannan wahayin, duk da haka, ya sa masu sharhi da yawa a shafukan sada zumunta suna ba da shawarar cewa babu wanin Bill Gates da ya kasance babban wanda ya amfana da shi - kuma mai yiwuwa fitaccen mai girma a baya - haɓakar ilimin taurari na BioNTech ko ma cewa BioNTech shine "kamfanin Gates."
Duk da yake gaskiya ne cewa Gidauniyar Gates - ba Gates da kansa ba - ta saka hannun jari a BioNTech a cikin yarjejeniyar da, kamar yadda za a gani a kasa, da alama gwamnatin Jamus ce ta kulla yarjejeniya, kuma yayin da wannan yarjejeniya ta kasance mai sha'awar lokacinta da wasu bayananta, mahimmancin tattalin arzikinta kawai ya wuce gona da iri.
Ya zuwa ranar 30 ga Disamba, 2020, hannun jarin farko na Gidauniyar Gates na hannun jarin BioNTech 1,038,674 ya wakilci kashi 0.43 ne kawai na jimlar kamfanin, kamar yadda a kasa. Yahoo Finance chart ya bayyana.
Wannan ya sanya Gidauniyar Gates a cikin manyan masu saka hannun jari a cikin BioNTech a lokacin. Amma cewa irin wannan ɗan ƙaramin hannun jari na iya cancanci ƙungiyar a matsayin babban mai riƙe da cibiyoyi ita kanta tana nuni da wani sanannen gaskiya game da BioNTech: wato, kamfani ne da ke da kusanci sosai, mafi yawan hannun jarinsa na mutane uku ne kawai.
Sakamakon haka, ƙayyadadden kaso na hannun jarin BioNTech ne kawai aka taɓa samuwa don siya ta Gidauniyar Gates ko wani.
Manyan masu hannun jarin uku sune Shugaba Ugur Sahin da tagwayen Strüngmann na Jamus, Andreas da Thomas, waɗanda suka ba da mafi yawan jarin iri na farko don kafa kamfanin a 2008.
A cewar BioNTech's Rahoton da aka ƙayyade na shekara-shekara ga SEC (shafi na 192), Strüngmanns sun mallaki hannun jari 105,613,143 wanda ke wakiltar kashi 43.4 na jimillar hannun jarin BioNTech: watau, a zahiri sau 100 fiye da Gidauniyar Gates da aka gudanar! Sahin ya mallaki hannun jari 42,262,039 wanda ke wakiltar kashi 17.4 na hannun jarin kamfanin. Tare, Sahin da Strüngmanns don haka suna sarrafa kusan kashi 61 na hannun jari na BioNTech.
Strüngmanns suna AT Impf a cikin tebur na ƙasa. AT Impf babban kamfani ne na ofishin iyali na ATHOS KG na tagwaye. Sahin shine kadai mai hannun jarin Medine.
Bugu da ƙari, kamar yadda bayanin kula na 1 zuwa tebur ya ƙayyade, "ATHOS KG ta AT Impf GmbH yana da ikon sarrafa BioNTech bisa ga yawan hannun jarinsa, wanda a zahiri ya ba ta damar yin amfani da mafi yawan haƙƙin jefa ƙuri'a don zartar da shawarwari a Babban Taronmu na Shekara-shekara."
Don haka, a takaice, BioNTech ba “kamfanin Gates bane,” amma a zahiri a Strüngmann Kamfanin, hannun jarin Gidauniyar Gates ya kasance kanana sosai.
Kamar yadda aka tattauna a Rubutun Substack da aka ambata da yawa ta Jordan Schachtel, Gidauniyar Gates ta sayar da hannun jari 890,000 a BioNTech, wanda ke wakiltar kashi 86 na hannun jarin da ta mallaka a baya. Dangane da lokaci da kuma juyin halittar farashin hannun jari na BioNTech, Schachtel ya kiyasta cewa gidauniyar ta yi dala miliyan 260 kan siyar ko kuma ta samu kashi 1,500 cikin XNUMX na jarin farko.
Wannan guguwar iska ce ta sa Gates ya zama kamar babban mai cin gajiyar nasarar BioNTech ta kwatsam a cikin yanayin rashin gaskiya na shafukan sada zumunta. Amma, ba lallai ba ne a faɗi, Strüngmanns sune manyan masu cin gajiyar nasarar BioNTech.
Hakika, kamar yadda kafafen yada labarai na Jamus suka yi ta yadawa a wancan lokacin, hauhawar farashin hannun jarin BioNTech a takaice ya sanya tagwayen cikin matsayi na manyan attajirai a Jamus, inda aka kiyasta kudinsu ya kai Yuro biliyan 52 ko kuma dala biliyan 62, lokacin da farashin hannun jarin ya kasance mafi girma a karshen shekarar 2021. Kamfanonin BioNTech kadai aka ruwaito sun kai sama da Yuro biliyan 42. (Dubi, alal misali, rahoton a cikin Jamusanci mako-mako tsananin nan.)
Tabbas, farashin hannun jarin BioNTech tun daga lokacin ya koma ƙasa kaɗan kusa da ƙasa. Amma tagwayen ba su bayyana cewa sun ƙi samun wasu tsabar kuɗi masu sanyi daga hannun jarinsu ba yayin da farashin hannun jari ya yi tsada.
Don haka, kusan Disamba 2020, lokacin da Gidauniyar Gates har yanzu tana riƙe duk abin hannunta na farko da kashi 0.43 na hannun jari na BioNTech, tagwayen Strüngmann a zahiri sun mallaki hannun jari 114,410,338 ko kusan 47.4 kashi Abubuwan da aka bayar na BioNTech. (Dubi shafi na 201 na rahoton shekara ta 2020 na BioNTech nan.) Wannan yana nufin cewa a halin yanzu tagwayen sun karkatar da kansu ba kusan hannun jari 900,000 ba, kamar Gidauniyar Gates, amma kusan kusan hannun jari. 9 miliyan.
Mun sani, haka ma, daga sauran SEC filaye cewa sun sayar da babban adadin hannun jari (sama da miliyan 8) daidai a cikin 2021, shekarar da farashin hannun jarin BioNTech ya kai kololuwar sa. Ya danganta da ainihin lokacin da aka yi a lokacin, da alama sun yi kusan sau goma fiye da Gates - watau, jigilar sama da dala biliyan 2 sabanin dala miliyan 260 na Gidauniyar Gates - kuma ba don amfanin kowace kungiya mai zaman kanta ba, amma kawai don nasu.
Bugu da ƙari, Gidauniyar Gates ba ita ce abokin haɗin gwiwar BioNTech kaɗai ba da a fili ya yi tunani mafi kyau game da samun kusanci da BioNTech a cikin dogon lokaci. Haka ma babu wanda ya yi illa kamfanin harhada magunguna na kasar Sin Fosun Pharma.
Wannan kuma ya dace da batunmu, tun da Fosun - ko kuma ana zargin ma, ta hanyar Fosun, Jam'iyyar Kwaminisanci ta Sin! - Hakanan ana gano shi sau da yawa a cikin sakonnin kafofin watsa labarun da kuma wasu masu sharhi kamar yadda "ainihin" mai BioNTech.
Ba haka ba ne kuma ba a taɓa yin irin wannan ba. Maimakon haka, a matsayin ɓangare na yarjejeniyar sa ta 2020 tare da BioNTech don tallata waccan rigakafin na Covid-19 a kasuwannin China, kamar gidauniyar Gates, ta sami karamin hannun jari a kamfanin na Jamus.
Wannan yarjejeniya, duk da haka, ta kasance matacciyar wasiƙa, tun da hukumomin China ba su taɓa amincewa da maganin da za a yi amfani da su a cikin ƙasa ba. Wannan na iya yin wani abu da cewa a karshen shekarar da ta gabata kamfanin na kasar Sin ya sayar da sama da kashi biyu bisa uku na hannun jarin BioNTech 1,576,000 da ya mallaka a farko. Dangane da lissafin ƙwararrun kasuwar Sinawa a Bamboo Works, wannan ya bar Fosun da kashi 0.2 bisa dari a BioNTech. Da yawa don "ikon" na kasar Sin na kamfanin…
Menene, to, na sanannen yarjejeniya ta watan Satumba 2019, gabanin IPO wanda Gidauniyar Gates ta sami hannun jari a BioNTech? Ta yaya Gates ya san ya saka hannun jari a kamfani wanda bai taɓa kusan kawowa kasuwa ba, ya taɓa yin asara kawai - kuma ya mai da hankali kan haɓaka maganin cutar kansa, ba maganin rigakafi daga cututtuka masu yaduwa ba, don taya! Da kyar wani ya taba jin labarin BioNTech.
To, hoton da ke ƙasa yana ba da ma'ana.
Ya fito ne daga taron rufe taron kolin kiwon lafiya na duniya na Oktoba 2018: taron da gwamnatin Jamus ta dauki nauyi, wanda ake gudanarwa kowace shekara a Berlin. (Duba bidiyo na taron koli na Kiwon Lafiyar Duniya na “haske”. nan.) Cibiyar karbar bakuncin ita ce asibitin koyarwa na jami'a na farko na Jamus, Charité, shugabar sashen ilimin cututtukan da ba wani bane illa Christian Drosten. Drosten ne, ba shakka, wanda ya ƙirƙiri sanannen ka'idar PCR da WHO za ta ɗauka a matsayin "ma'aunin zinariya" don gano cututtukan Covid-19.
Baya ga shugabar gwamnatin Jamus Angela Merkel a matakin tsakiya, ba shakka, za ku lura da Bill Gates (wanda cibiyar sadarwar Grand Challenges ce ta shirya taron) kai tsaye zuwa hannun dama da Darakta-Janar na WHO Tedros, dan nisa zuwa hagu.
Amma mutumin da ba shi da kunnen doki kai tsaye da Tedros na hagu shi ne ya fi ba mu sha'awa a nan. Don wannan ba kowa bane illa Shugaban Kamfanin BioNTech Ugur Sahin.
Taron kolin lafiya na duniya na 2018 ne karkashin jagorancin shugabar gwamnati Merkel wanda ya hada Gates da Sahin. Da wuya Gates ya taba jin labarin Sahin ko kamfaninsa kafin lokacin.
Ita kuwa gwamnatin Jamus ta san Sahin da BioNTech sosai. Don, kamar yadda aka shafa a cikin labarin na Nuwamba 2021 nan, Gwamnatin Jamus ita ce ta dauki nauyin kamfanin, dukansu sun dauki nauyin kafa shi tare da taimakawa wajen ci gaba da tafiya tare da tallafi a cikin shekaru masu yawa lokacin da BioNTech ya samar da komai.
-
Robert Kogon shi ne sunan alkalami na wani ɗan jarida da ake bugawa da yawa wanda ke yin rubuce-rubuce kan al'amuran Turai.
Duba dukkan posts
